Cannabis fails to slow progress of multiple sclerosis in UK study
Cannabis capsules failed to slow the progression of multiple sclerosis in a large British study.
There were quite a high expectations that trials of (THC), a key active ingredient in cannabis, would prove to be a treatment for secondary progressive multiple sclerosis (SPMS).
Currently there is nothing available for sufferers of SPMS except symptom relief. Phase 3 trials for natalizumab have just begun and it is thought this might stop SPMS but it will be a couple of years before the results will be known.
Click here to read the article